Tradestie Institutional Equity Comparison Engine

ABSI vs ABCL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABCL Overall Edge

ABCL Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AbCellera Biologics Inc. Common Shares (ABCL) driven by superior Valuation, Growth & Margin, Momentum & Technical while ABSI counters with relative strength in Options & Structure. Fundamentally, ABSI trades at N/M Forward P/E with -9108.3% operating margin (-19.6% YoY revenue) versus ABCL at 27.6x Forward P/E and -1550.0% operating margin (-76.3% YoY). In options structure, ABSI sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro) against ABCL sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ABCL
ABSI N/M vs ABCL 27.6x Fwd P/E
Growth & Margin Winner ABCL
Op Margin -9108.3% vs -1550.0% ยท YoY -19.6% vs -76.3%
Momentum & Technical Winner ABCL
1Y +192.6% vs +209.0% ยท 52W Pos 53% vs 69%
Options & Structure Winner ABSI
BREAKDOWN (15th %ile IV) vs CONSOLIDATION (25th %ile IV)
ABSI NASDAQ
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.72
-8.58% 1D
Market Cap $1.6B
1M Return -6.36%
1Y Return +192.61%
Forward P/E N/M
Unified AI Score
37.5 / 100 SELL
Tech 27.0 Fund 51.0 Flow 71.0 Mom 60.0
ABCL NASDAQ
AbCellera Biologics Inc. Common Shares
Pharmaceutical Preparations
$11.19
-2.65% 1D
Market Cap $3.8B
1M Return -5.21%
1Y Return +208.98%
Forward P/E 27.6x
Unified AI Score
60.7 / 100 BUY
Tech 52.0 Fund 59.0 Flow 67.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABSI +192.61% ABCL +208.98% Spread: +16.37 pp (ABCL Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ABSI Revenue ABCL Revenue ABSI Op. Margin ABCL Op. Margin Margin Edge
FY2019 N/A $10M N/A -35.5% ABCL
FY2020 $0M $230M -278.3% 66.9% ABCL
FY2021 $0M $380M -1573.4% 54.5% ABCL
FY2022 $10M $490M -1857.5% 44.6% ABCL
FY2023 $10M $40M -2020.2% -623.8% ABCL
FY2024 $0M $30M -2401.6% -1091.7% ABCL
FY2025 $0M $80M -4297.0% -289.0% ABCL

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABSI (2) vs ABCL (8)
Institutional Metric ABSI ABCL Criterion Row Winner
Market Capitalization Scale $1.6B $3.8B Larger Scale ABCL
Trailing P/E Ratio Valuation N/M 27.6x Lower Multiple ABCL
Forward P/E Ratio Valuation N/M 27.6x Lower Multiple ABCL
Revenue Growth (YoY) Growth -19.6% -76.3% Higher Growth ABSI
Operating Margin (TTM) Profitability -9108.3% -1550.0% Higher Margin ABCL
Net Profit Margin Profitability 0.0% -248.8% Higher Margin ABSI
Return on Equity (ROE) Capital Efficiency -58.6% -17.3% Higher ROE ABCL
52-Week Range Position Momentum 53% ($2โ€“$13) 69% ($3โ€“$15) Stronger Trend ABCL
Beta / 30D Volatility Risk Regime 3.31ฮฒ ยท 126% Vol 2.31ฮฒ ยท 87% Vol Lower Realized Risk ABCL
Unified Institutional Score Composite Signal 37.5 / 100 (SELL) 60.7 / 100 (BUY) Higher Composite ABCL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABSI vs ABCL Buy Guide
ABSI BREAKDOWN
97d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live ABSI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABCL CONSOLIDATION
34d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live ABCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABSI nor ABCL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.